Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
Shanghai Institute of Materia Medica · Chinese Academy of Sciences · +4 more institutions
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVReviewNEXTNext Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic AreasYu Zhou†, Jiang Wang†, Zhanni Gu†, Shuni Wang†, Wei Zhu†, José Luis Aceña*‡§, Vadim A. Soloshonok*‡∥, Kunisuke Izawa*⊥, and Hong Liu*†View Author Information† Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China‡ Department of Organic Chemistry I, Faculty of Chemistry, University of the Basque Country UPV/EHU, Paseo Manuel Lardizábal 3, 20018 San Sebastián, Spain§ Department of Organic…
Citation impact
- FWCI
- 140.39
- Percentile
- 100%
- References
- 563
Authors
9- YZYu ZhouCorresponding
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- JWJiang Wang
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- ZGZhanni Gu
Chinese Academy of Sciences, Shanghai Institute of Materia Medica
- SWShuni Wang
Chinese Academy of Sciences, Shanghai Institute of Materia Medica
- WZWei Zhu
Chinese Academy of Sciences, Shanghai Institute of Materia Medica
Topics & keywords
- Library science
- China
- Web of science
- Chemistry
- Political science
- Computer science
- MEDLINE
- Law